Artificial intelligence in psoriasis: Where we are and where we are going

被引:7
作者
Liu, Zhenhua [1 ,2 ]
Wang, Xinyu [3 ]
Ma, Yao [4 ]
Lin, Yiting [2 ]
Wang, Gang [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Shaanxi, Peoples R China
[2] Fourth Mil Med Univ, Tangdu Hosp, Dept Dermatol, 1 Xinsi Rd, Xian 710038, Shaanxi, Peoples R China
[3] Valdosta State Univ, Dept Econ Finance & Healthcare Adm, Valdosta, GA 31602 USA
[4] Fourth Mil Med Univ, Student Brigade Basic Med Sch, Xian, Peoples R China
基金
中国国家自然科学基金;
关键词
artificial intelligence; deep learning; dermatology; machine learning; psoriasis; CONVOLUTIONAL NEURAL-NETWORKS; RISK STRATIFICATION; SEVERITY INDEX; MACHINE VISION; SKIN-CANCER; SEGMENTATION; CLASSIFICATION; MANAGEMENT; ARTHRITIS; IMAGES;
D O I
10.1111/exd.14938
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Artificial intelligence (AI) is a field of computer science that involves the development of programs designed to replicate human cognitive processes and the analysis of complex data. In dermatology, which is predominantly a visual-based diagnostic field, AI has become increasingly important in improving professional processes, particularly in the diagnosis of psoriasis. In this review, we summarized current AI applications in psoriasis: (i) diagnosis, including identification, classification, lesion segmentation, lesion severity and area scoring; (ii) treatment, including prediction treatment efficiency and prediction candidate drugs; (iii) management, including e-health and preventive medicine. Key challenges and future aspects of AI in psoriasis were also discussed, in hope of providing potential directions for future studies.
引用
收藏
页码:1884 / 1899
页数:16
相关论文
共 50 条
  • [31] Artificial Intelligence in Corneal Diagnosis: Where Are we?
    Bernardo T. Lopes
    Ashkan Eliasy
    Renato Ambrosio
    Current Ophthalmology Reports, 2019, 7 : 204 - 211
  • [32] Artificial Intelligence in Corneal Diagnosis: Where Are we?
    Lopes, Bernardo T.
    Eliasy, Ashkan
    Ambrosio Jr, Renato
    CURRENT OPHTHALMOLOGY REPORTS, 2019, 7 (03) : 204 - 211
  • [33] Artificial Intelligence in Dermatology-Where We Are and the Way to the Future: A Review
    Hogarty, Daniel T.
    Su, John C.
    Phan, Kevin
    Attia, Mohamed
    Hossny, Mohammed
    Nahavandi, Saeid
    Lenane, Patricia
    Moloney, Fergal J.
    Yazdabadi, Anousha
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020, 21 (01) : 41 - 47
  • [34] Artificial intelligence in gastroenterology: where are we heading?
    Sung, Joseph J. Y.
    Poon, Nicholas C. H.
    FRONTIERS OF MEDICINE, 2020, 14 (04) : 511 - 517
  • [35] Targeting therapy in pemphigus: Where are we now and where are we going?
    Abulikemu, Kailibinuer
    Hu, Fengxia
    Liang, Junqin
    Kang, Xiaojing
    HELIYON, 2023, 9 (06)
  • [36] Neurodevelopmental Disorders: Where we are today and where we're going
    Lopez, Isabel
    Forster, Jorge
    REVISTA MEDICA CLINICA LAS CONDES, 2022, 33 (04): : 367 - 378
  • [37] State of the art of research on Rivaroxaban: where we are and where we are going
    Vizzari, G.
    Ando, G.
    Piccione, M. Cusma
    Trio, O.
    Carerj, M. L.
    Luzza, F.
    Oreto, G.
    Zito, C.
    MULTIDISCIPLINARY APPROACH TO CARDIOVASCULAR DISEASES, 2016, : 97 - 102
  • [38] Natriuretic peptides in heart failure: where we are, where we are going
    Correale, Michele
    Totaro, Antonio
    Greco, Carmen
    Brunetti, Natale Daniele
    Di Biase, Matteo
    INTERNAL AND EMERGENCY MEDICINE, 2011, 6 (04) : 381 - 381
  • [39] Artificial intelligence in orthodontics: Where are we now? A scoping review
    Monill-Gonzalez, Anna
    Rovira-Calatayud, Laia
    d'Oliveira, Nuno Gustavo
    Ustrell-Torrent, Josep M.
    ORTHODONTICS & CRANIOFACIAL RESEARCH, 2021, 24 : 6 - 15
  • [40] The future landscape of biosimilars in rheumatology: Where we are where we are going
    Scheinberg, Morton
    Azevedo, Valderilio
    AUTOIMMUNITY REVIEWS, 2019, 18 (02) : 203 - 208